Behaviour of Lymphocyte Subsets in Response to Immunotherapy with Propionibacterium avidum KP-40 in Cancer Patients
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Zentralblatt für Bakteriologie
- Vol. 273 (3) , 386-390
- https://doi.org/10.1016/s0934-8840(11)80442-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Immunomodulation by propionibacteriaClinical Immunology Newsletter, 1985
- Small-cell lung cancer and immunochemotherapy withPropionibacterium granulosum KP 45Zeitschrift für Krebsforschung und Klinische Onkologie, 1985
- Stimulatory Effect of Propionibacterium Granulosum KP-45, Glucan and Pyran Copolymer on the Activity of Natural Killer (NK) Cells in Murine LungsImmunobiology, 1984
- A phase-II trial of Corynebacterium parvum as adjuvant to surgery in the treatment of operable lung cancerCancer Immunology, Immunotherapy, 1983
- Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanomaCancer, 1983
- A trial of nonspecific immunotherapy using systemic C. parvum in treated patients with Dukes B and C colorectal cancerBritish Journal of Cancer, 1982
- The correlation of susceptibility of differentPropionibacterium strains to macrophage killing and antitumor activityMedical Microbiology and Immunology, 1980
- The in vivo cytostatic effect induced by Propionibacterium granulosum on murine tumor cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1980
- Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvumNature, 1966